Experiences with
Rituximab2,596 public posts
Want to take advantage of all our features? Just log in!
or
Scottish Medicines Consortium approves Venetoclax + Rituximab Treatment for relapsed/refractory CLL
Venetoclax has been approved by the Scottish Medicines Consortium (SMC) for treating adults with CLL,who have already tried at least one treatment, in combination with another cancer medicine called rituximab. This is in line with the NICE decision for NHS England.
Ibrutinib and Rituximab (IR) is Superior to Chemo-immunotherapy (CIT) in CLL” Big News, or is it really, and did they get it right?
For the whole story, please take a look at my review of latest data and context of this important research.
https://cllsociety.org/2019/08/ibrutinib-and-rituximab-ir-is-superior-to-chemo-immunotherapy-cit-in-cll-big-news-or-is-it-really-and-did-they-get-it-right/ Brian Koffman CLLSociety,org